The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Immunomodulatory spherical nucleic acids
Open accessAbstract
Significance: We show that by organizing immunomodulatory nucleic acids into spherical nucleic acid (SNA) form, significant increases in activity are observed. Treatment of mice with cancer using immunostimulatory SNAs and nonalcoholic steatohepatitis (NASH) using immunoregulatory SNAs leads to improved disease outcomes vs. their unstructured counterparts. These improvements derive from several key SNA properties, including rapid cellular uptake, endosomal delivery, and multivalent binding. Overall, this work underscores the importance of the spatial orientation and presentation of oligonucleotides in the design of novel immunomodulators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
A DNA-based method for rationally assembling nanoparticles into macroscopic materials
Mirkin, C. A., Letsinger, R. L., Mucic, R. C., & Storhoff, J. J. (1996) · Nature · doi:10.1038/382607a0 · Cited by 6,683
Self-citationPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Nivolumab in Previously Untreated Melanoma without BRAF Mutation
Robert, C., Long, G. V., Brady, B., Dutriaux, C., Maio, M., Mortier, L., Hassel, J. C., Rutkowski, P., McNeil, C., Kalinka-Warzocha, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412082 · Cited by 5,519
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Cutler, J. I., Auyeung, E., & Mirkin, C. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209351u · Cited by 1,119
Self-citationStructure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Cheever, M. A., & Higano, C. S. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3126 · Cited by 780
Therapeutic vaccines for cancer: an overview of clinical trials
Melero, I., Gaudernack, G., Gerritsen, W., Huber, C., Parmiani, G., Scholl, S., Thatcher, N., Wagstaff, J., Zielinski, C., Faulkner, I., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.111 · Cited by 776
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells
Hartmann, G., & Krieg, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.944 · Cited by 605 · cited 1×
“phosphorothioate backbones for human and murine TLR ligands, respectively (31); and (vi) the studied IS-SNAs did not induce significant production of IFN-α in hPBMCs in vitro under the conditions studied (Fig.”
MethodSpherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
Self-citationImmunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis
Creticos, P. S., Schroeder, J. T., Hamilton, R. G., Balcer-Whaley, S. L., Khattignavong, A. P., Lindblad, R., Li, H., Coffman, R., Seyfert, V., Eiden, J. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052916 · Cited by 562
Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
Choi, C. H. J., Hao, L., Narayan, S. P., Auyeung, E., & Mirkin, C. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305804110 · Cited by 533
Self-citationSilver Nanoparticle−Oligonucleotide Conjugates Based on DNA with Triple Cyclic Disulfide Moieties
Lee, J.-S., Lytton-Jean, A. K. R., Hurst, S. J., & Mirkin, C. A. (2007) · Nano Letters · doi:10.1021/nl071108g · Cited by 500
Self-citationTopical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation
Zheng, D., Giljohann, D. A., Chen, D. L., Massich, M. D., Wang, X.-Q., Iordanov, H., Mirkin, C. A., & Paller, A. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118425109 · Cited by 409
Self-citationTherapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Getts, D. R., Terry, R. L., Getts, M. T., Deffrasnes, C., Müller, M., van Vreden, C., Ashhurst, T. M., Chami, B., McCarthy, D., Wu, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007563 · Cited by 378
Patel, P. C., Giljohann, D. A., Daniel, W. L., Zheng, D., Prigodich, A. E., & Mirkin, C. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc1002423 · Cited by 366
Self-citationFujii, M., Shibazaki, Y., Wakamatsu, K., Honda, Y., Kawauchi, Y., Suzuki, K., Arumugam, S., Watanabe, K., Ichida, T., Asakura, H., et al. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0016-1 · Cited by 355
de Titta, A., Ballester, M., Julier, Z., Nembrini, C., Jeanbart, L., van der Vlies, A. J., Swartz, M. A., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313152110 · Cited by 254
Intracellular Fate of Spherical Nucleic Acid Nanoparticle Conjugates
Wu, X. A., Choi, C. H. J., Zhang, C., Hao, L., & Mirkin, C. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503010a · Cited by 245
Self-citationLiposomal Spherical Nucleic Acids
Banga, R. J., Chernyak, N., Narayan, S. P., Nguyen, S. T., & Mirkin, C. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504845f · Cited by 210
Self-citationImageable Antigen‐Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
Lee, I., Kwon, H., An, S., Kim, D., Kim, S., Yu, M. K., Lee, J., Lee, T., Im, S., & Jon, S. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203193 · Cited by 194
Zhu, X., Nishimura, F., Sasaki, K., Fujita, M., Dusak, J. E., Eguchi, J., Fellows-Mayle, W., Storkus, W. J., Walker, P. R., Salazar, A. M., et al. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-10 · Cited by 194
Engineering antigens for in situ erythrocyte binding induces T-cell deletion
Kontos, S., Kourtis, I. C., Dane, K. Y., & Hubbell, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216353110 · Cited by 190
Lin, A. Y., Almeida, J. P. M., Bear, A. S., Liu, N., Luo, L., Foster, A. E., & Drezek, R. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063550 · Cited by 155
Therapeutic Vaccines for Chronic Infections
Autran, B., Carcelain, G., Combadière, B., & Debré, P. (2004) · Science · doi:10.1126/science.1100600 · Cited by 139
Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery
Nguyen, D. N., Mahon, K. P., Chikh, G., Kim, P., Chung, H., Vicari, A. P., Love, K. T., Goldberg, M. S., Chen, S., Krieg, A. Μ., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121423109 · Cited by 110
A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
Anderson, R. J., Tang, C., Daniels, N. J., Compton, B. J., Hayman, C. M., Johnston, K. A., Knight, D. A., Gasser, O., Poyntz, H., Ferguson, P. M., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1640 · Cited by 89
Jiang, W., Zhu, F., Bhagat, L., Yu, D. S., Tang, J. X., Kandimalla, E. R., Monica, N. L., & Agrawal, S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.57 · Cited by 87
Yu, D. S., Zhao, Q., Kandimalla, E. R., & Agrawal, S. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00537-0 · Cited by 72
Cooper, C., & Mackie, D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.162 · Cited by 69
Zhu, F., Jiang, W., Bhagat, L., Wang, D., Yu, D. S., Tang, J. X., Kandimalla, E. R., Monica, N. L., & Agrawal, S. (2013) · Autoimmunity · doi:10.3109/08916934.2013.798651 · Cited by 64
Lenert, P. S., Yasuda, K., Busconi, L., Nelson, P., Fleenor, C. J., Ratnabalasuriar, R. S., Nagy, P. L., Ashman, R. F., Rifkin, I. R., & Marshak‐Rothstein, A. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2710 · Cited by 52
Nanoparticle Therapy for Allergic and Inflammatory Disease
Fraser, C. (2010) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152310790711683 · Cited by 5
Cited by
Rethinking cancer nanotheranostics
Chen, H., Zhang, W., Zhu, G., Xie, J., & Chen, X. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.24 · Cited by 1,102
Enhancing cancer immunotherapy with nanomedicine
Irvine, D. J., & Dane, E. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0269-6 · Cited by 882
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Improving cancer immunotherapy through nanotechnology
Goldberg, M. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0186-9 · Cited by 628
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
Metadata
- Authors
- Radovic-Moreno, A. F., Chernyak, N., Mader, C. C., Nallagatla, S., Kang, R. S., Hao, L., Walker, D. A., Halo, T. L., Merkel, T. J., Rische, C. H., Anantatmula, S., Burkhart, M., Mirkin, C. A., & Gryaznov, S. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2015-03-16
- Volume
- 112
- Issue
- 13
- Pages
- 3892-3897
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W4236536513
- Cited by
- 259
- References
- 35
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.